Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly
Aug 26
Indian (NIFTY) Pharma Industry Analysis
UpdatedSep 24, 2023
DataAggregated Company Financials
Companies154
- 7D-2.9%
- 3M11.7%
- 1Y23.7%
- YTD21.5%
Over the last 7 days, the Pharma industry has dropped 2.9%, driven by pullbacks in Dr. Reddy's Laboratories and Zydus Lifesciences of 5.3% and 7.7%, respectively. Meanwhile, Bajaj HealthCare actually outperformed within the industry, gaining 12% in the last week. In the past year, the industry has gained 24%. Earnings are forecast to grow by 18% annually.
Industry Valuation and Performance
Has the Indian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 25 Sep 2023 | ₹12.9t | ₹3.3t | ₹369.5b | 29.7x | 35x | 4x |
| Wed, 23 Aug 2023 | ₹13.1t | ₹3.3t | ₹367.1b | 29.2x | 35.6x | 4x |
| Fri, 21 Jul 2023 | ₹12.2t | ₹3.2t | ₹342.2b | 26.3x | 35.8x | 3.9x |
| Sun, 18 Jun 2023 | ₹11.4t | ₹3.2t | ₹342.4b | 27.1x | 33.2x | 3.6x |
| Tue, 16 May 2023 | ₹10.5t | ₹3.1t | ₹309.4b | 26.9x | 33.9x | 3.4x |
| Thu, 13 Apr 2023 | ₹9.9t | ₹3.0t | ₹277.5b | 25.8x | 35.7x | 3.3x |
| Sat, 11 Mar 2023 | ₹9.4t | ₹3.0t | ₹277.5b | 24.4x | 33.7x | 3.1x |
| Mon, 06 Feb 2023 | ₹9.7t | ₹3.0t | ₹285.2b | 24.4x | 33.9x | 3.3x |
| Wed, 04 Jan 2023 | ₹9.9t | ₹2.9t | ₹274.9b | 26.5x | 36.1x | 3.5x |
| Fri, 02 Dec 2022 | ₹10.2t | ₹2.9t | ₹274.9b | 26.5x | 37.2x | 3.6x |
| Sun, 30 Oct 2022 | ₹10.2t | ₹2.8t | ₹260.5b | 23.7x | 39.1x | 3.6x |
| Tue, 27 Sep 2022 | ₹9.5t | ₹2.8t | ₹261.9b | 23.1x | 36.3x | 3.4x |
| Thu, 25 Aug 2022 | ₹9.7t | ₹2.8t | ₹261.9b | 22.7x | 37.1x | 3.5x |
| Sat, 23 Jul 2022 | ₹9.7t | ₹2.7t | ₹273.4b | 22.3x | 35.3x | 3.6x |
| Mon, 20 Jun 2022 | ₹8.9t | ₹2.8t | ₹273.8b | 20.4x | 32.5x | 3.2x |
| Wed, 18 May 2022 | ₹9.4t | ₹2.7t | ₹332.4b | 21.4x | 28.3x | 3.5x |
| Fri, 15 Apr 2022 | ₹10.2t | ₹2.7t | ₹338.0b | 24.3x | 30.3x | 3.8x |
| Sun, 13 Mar 2022 | ₹9.9t | ₹2.7t | ₹337.9b | 23.4x | 29.4x | 3.7x |
| Tue, 08 Feb 2022 | ₹10.1t | ₹2.7t | ₹368.3b | 24.6x | 27.4x | 3.8x |
| Thu, 06 Jan 2022 | ₹10.7t | ₹2.7t | ₹360.6b | 26.4x | 29.6x | 4x |
| Sat, 04 Dec 2021 | ₹10.1t | ₹2.7t | ₹360.3b | 22.9x | 28x | 3.8x |
| Mon, 01 Nov 2021 | ₹10.4t | ₹2.6t | ₹363.0b | 23.4x | 28.6x | 3.9x |
| Wed, 29 Sep 2021 | ₹10.8t | ₹2.6t | ₹375.7b | 25.8x | 28.6x | 4.1x |
| Fri, 27 Aug 2021 | ₹10.7t | ₹2.6t | ₹375.2b | 23.3x | 28.4x | 4.1x |
| Sat, 03 Jul 2021 | ₹10.7t | ₹2.6t | ₹371.5b | 24x | 28.9x | 4.2x |
| Tue, 06 Apr 2021 | ₹9.0t | ₹2.5t | ₹332.3b | 16.1x | 27.1x | 3.6x |
| Fri, 08 Jan 2021 | ₹9.3t | ₹2.5t | ₹320.8b | 19x | 29.1x | 3.8x |
| Thu, 01 Oct 2020 | ₹8.3t | ₹2.4t | ₹234.1b | 20.6x | 35.6x | 3.5x |
Price to Earnings Ratio
35.6x
Current Industry PE
- Investors are relatively neutral on the Indian Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 32.3x.
- The industry is trading close to its 3-year average PS ratio of 3.7x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 16% per year over the last three years.
- Revenues for these companies have grown 11% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Indian Pharma compare with similar industries?
| IN Market | -1.77% | |
| Healthcare | -2.97% | |
| Pharma | -2.91% | |
| Pharma | -2.91% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| STAR Strides Pharma Science | ₹535.85 | 10.2% +₹4.5b | 72.9% | PS1.3x | |
| MANKIND Mankind Pharma | ₹1.74k | 0.5% +₹3.2b | n/a | PE47.3x | |
| 524558 Neuland Laboratories | ₹3.81k | 4.2% +₹2.0b | 181.3% | PE22.7x | |
| MARKSANS Marksans Pharma | ₹105.80 | 4.2% +₹1.9b | 121.1% | PE17.5x | |
| AJANTPHARM Ajanta Pharma | ₹1.68k | 0.9% +₹1.8b | 31.1% | PE34.1x |